Artificial intelligence is rapidly becoming an important part of the life sciences industry, influencing areas such as research, clinical development, patient engagement, manufacturing, supply chain operations, and commercial activities. As organizations move beyond experimentation and begin integrating AI into everyday workflows, the focus is shifting from simply adopting new technologies to achieving measurable business outcomes. AI Application in Business is therefore becoming increasingly important for improving productivity, streamlining complex processes, supporting faster and more informed decision-making, and creating better experiences for customers and patients.
Turning AI investments into meaningful results, however, requires more than deploying individual AI tools. Organizations need strong data foundations, modern enterprise technology, scalable digital infrastructure, and clear strategies for integrating AI into existing business processes. STL Digital works with enterprises across these areas, bringing together AI capabilities, data expertise, enterprise technology, and digital transformation solutions to help organizations develop practical approaches to AI adoption. With the right foundations and a clear focus on business priorities, life sciences organizations can use AI to support innovation while creating sustainable and measurable business value.
The Growing Gap Between AI Adoption and Value
Life sciences organizations are investing heavily in AI, but adoption alone does not guarantee measurable value. Many companies have launched pilots and proof-of-concepts across departments, yet only some have successfully integrated these initiatives into core business processes. This creates a growing gap between AI adoption and business impact. An organization may have advanced AI models, multiple AI applications, and employees experimenting with generative technologies, while still struggling to demonstrate improvements in revenue, productivity, operational efficiency, or customer experience.
Start With Business Outcomes
The first step is to define what the organization wants AI to achieve before deciding which technology to deploy. For a pharmaceutical company, an AI initiative might focus on reducing the time required to analyze clinical information. In manufacturing, the objective could be improving production quality or predicting equipment issues. Commercial teams may focus on improving customer engagement, while patient-facing functions could use AI to streamline onboarding or support adherence. This outcome-led approach makes AI for Enterprise more closely aligned with organizational priorities.
According to Forrester, high AI adopters are more likely than low adopters to focus on customer experience, with 52% compared with 44%, and marketing optimization, with 48% compared with 30%. Forrester also reports that CEOs are the executives most likely to drive AI business strategy among high adopters, at 25%. These findings highlight the importance of treating AI as a business transformation priority rather than simply a technology initiative. When AI is connected to customer needs and strategic objectives, organizations have a clearer framework for determining whether investments are creating value.
Build the Data Foundation for AI
Data is one of the most important foundations for closing the AI value gap. Even sophisticated AI models can produce limited business value when data is fragmented, inconsistent, outdated, or difficult to access. Life sciences organizations manage extensive datasets across research, clinical trials, manufacturing, supply chains, regulatory processes, customer interactions, and enterprise applications. Bringing these datasets together in a secure and governed environment can help organizations create more reliable foundations for AI.
This is where Data Analytics and AI Services can support the transition from raw information to actionable intelligence. Organizations can improve data quality, establish governance processes, create integrated data environments, and develop analytics capabilities that support both AI applications and broader decision-making. Forrester reports that 47% of high AI adopters work with consulting partners to prepare their data and systems, compared with 26% of low adopters. This highlights how data infrastructure and organizational readiness can influence an organization’s ability to move AI initiatives beyond experimentation.
Move From AI Pilots to Real-World Applications
A successful AI pilot is only the beginning. The more difficult challenge is integrating that capability into everyday business operations. A pilot may work effectively within a controlled environment with limited users and a narrow dataset. Scaling it across an enterprise requires secure integrations, reliable data pipelines, application connectivity, governance, monitoring, and employee adoption. For life sciences organizations, this could mean connecting an AI solution with clinical systems, manufacturing platforms, customer applications, regulatory workflows, or enterprise data environments.
A scalable AI Application in Business strategy should therefore consider the complete lifecycle of an AI solution—from identifying the use case and developing the model to deployment, monitoring, measurement, and continuous improvement. Organizations should also identify which AI capabilities can be reused across multiple use cases. Shared data platforms, integration frameworks, governance models, and AI development practices can make it easier to expand successful initiatives without starting from scratch each time.
Agentic AI Can Expand the Value Opportunity
The next phase of AI adoption is also moving toward systems that can do more than generate information. Agentic AI can support workflows by interacting with systems, coordinating tasks, and assisting employees with complex operational processes.
According to Statista, just over half of healthcare and life sciences providers expected artificial intelligence to have a major impact on advanced medical imaging and diagnostics over the following five years. The survey also found that almost 40% of respondents working in digital healthcare believed AI would have a considerable impact on precision medicine. These findings reflect the growing expectations around AI across the healthcare and life sciences landscape, particularly in areas where organizations rely on large volumes of data, advanced analysis, and increasingly personalized approaches to patient care.
This illustrates how AI can increasingly move from providing information toward supporting specific operational activities. However, organizations still need to establish appropriate oversight, governance, security, and human involvement, particularly when AI operates within regulated environments.
Connect AI With Digital Transformation
AI value is difficult to sustain when AI applications operate separately from the organization’s broader technology environment. A strong Digital Transformation Strategy can provide the framework for connecting AI with application modernization, data platforms, cloud infrastructure, cybersecurity, and redesigned business processes.
For example, an AI system that identifies potential issues in a manufacturing process can generate valuable insights, but the impact is limited if employees cannot easily access those insights or take action through connected systems. Similarly, an AI solution supporting clinical operations can create greater value when it is integrated into the workflows and applications already used by clinical teams. This means organizations need to think beyond individual AI models. The objective should be to create connected digital environments in which data, applications, AI capabilities, and employees can work together effectively.
Prepare the Workforce for AI-Enabled Work
The AI value gap is not only a technology challenge. It is also a workforce challenge. Employees need to understand how AI fits into their roles, how to use AI responsibly, how to validate outputs, and when human judgment should take priority. A practical AI Application in Business approach should therefore include employees as an important part of the AI adoption strategy rather than focusing only on technology deployment.
Create a Responsible AI Operating Model
As AI becomes embedded across the organization, governance must evolve alongside adoption. Life sciences companies need clear policies for data access, privacy, security, model oversight, human review, accountability, and regulatory compliance. Governance should be incorporated into AI development from the beginning rather than added after deployment. An effective AI for Enterprise operating model can establish clear responsibilities across business leaders, technology teams, data specialists, domain experts, compliance functions, and risk teams. This allows organizations to evaluate AI opportunities consistently, prioritize initiatives based on business value, and create appropriate controls for different levels of AI risk.
From Adoption to Sustainable Value
Closing the AI value gap ultimately requires a shift from measuring how much AI an organization has adopted to measuring what that AI has actually changed. A focused AI Application in Business approach can help organizations evaluate AI initiatives based on their contribution to productivity, operational efficiency, decision-making, customer experience, and other measurable business outcomes.
Organizations can begin by identifying high-value business problems, establishing reliable data foundations, integrating AI into existing workflows, preparing employees, and defining measurable outcomes. Successful initiatives can then be scaled through reusable technology, governance, and operating frameworks. Digital Transformation Strategy plays an important role in bringing these elements together. By connecting AI, data, applications, people, and processes, life sciences organizations can create an environment where AI becomes part of how the business operates rather than remaining a collection of disconnected experiments.
Conclusion
The life sciences industry is moving rapidly from AI experimentation toward broader enterprise adoption, but adoption alone does not close the AI value gap. Sustainable value comes from connecting AI investments with clear business priorities, reliable data, integrated technology, workforce capabilities, responsible governance, and measurable outcomes.The next stage of AI in life sciences will therefore be defined not simply by how many organizations adopt AI, but by how effectively they turn AI capabilities into measurable improvements in research, operations, commercial performance, employee productivity, and customer or patient experiences.
With capabilities across AI, data, enterprise technology, and digital transformation, partnering with STL Digital can help organizations build the foundations needed to scale AI responsibly, connect technology with business priorities, and turn AI investments into measurable and sustainable outcomes.
